期刊文献+

宫颈上皮内瘤变及宫颈鳞癌中CD34与MK蛋白的临床价值 被引量:2

Clinical value of CD34 and MK protein in cervical intraepithelial neoplasia and cervical squamous cell
原文传递
导出
摘要 目的:探讨CD34与MK蛋白在宫颈上皮内瘤变(CIN)及宫颈鳞癌中的临床价值。方法:对医院妇科收治的30例CIN及40例宫颈癌患者的临床资料进行回顾性分析,取患者组织标本进行常规组织学处理,检测标本中CD34与MK蛋白的表达情况。结果:MK蛋白在CIN及宫颈鳞癌组织中的表达率分别为20.0%、57.5%,两组间比较差异有统计学意义(P<0.05),但是CIN分期间比较差异无统计学意义(P>0.05)。CD34在两种疾病中表达较高,两组比较差异有统计学意义(P<0.05),但是CIN分期间比较差异无统计学意义(P>0.05)。结论:CD34与MK蛋白在CIN及宫颈癌中高度表达,可用于指导治疗及判断预后具有十分重要的临床价值。 Objective: To investigate the clinical value of CD34 and MK protein in cervical intraepithelial neoplasia and cervical squamous cell carcinoma. Methods: 30 cases of gynecological cervical intraepithelial neoplasia and 40 eases of cervical cancer clinical data were retrospectively analyzed, tissue samples were taken for routine histological processing to test specimens of CD34 and MK protein expres- sions. Results: MK protein in cervical intraepithelial neoplasia and cervical squamous cell carcinoma were 20% , 57. 5% , the difference between the two groups was statistically significant ( P 〈 0.05 ), but there was no significant difference among different cervical intraepithelial neoplasias period ( P 〉 0. 05 ) . CD34 expression in both diseases was higher, the difference was statistically significant ( P 〈 0. 05 ), but there was no significant difference among different cervical intraepithelial neoplasias period ( P 〉 0. 05 ) . Conclusion: CD34 and MK protein in cervical intraepithelial neoplasia and cervical are highly expressed and can be used to guide treatment and prognosis, which has very important clinical value.
出处 《中国妇幼保健》 CAS 北大核心 2014年第1期139-141,共3页 Maternal and Child Health Care of China
关键词 宫颈上皮内瘤变 宫颈鳞癌 CD34、MK蛋白 Cervical intraepithelial neoplasia Cervical squamous cell carcinoma CD34, MK protein
  • 相关文献

参考文献9

二级参考文献103

  • 1Wang, Cheng-Gang,Ye, Ying-Jiang,Yuan, Jing,Liu, Fang-Fang,Zhang, Hui,Wang, Shan.EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis[J].World Journal of Gastroenterology,2010,16(19):2421-2427. 被引量:16
  • 2方静,薛艳,周党侠,苟文丽.EZH2基因在宫颈癌中的表达及其意义[J].西安交通大学学报(医学版),2011,32(6):758-760. 被引量:10
  • 3李永明,冯学超,杨红,麻彤辉.水通道蛋白AQP1的表达促进SMMC-7221人肝癌细胞的迁移[J].科学通报,2006,51(17):2024-2029. 被引量:12
  • 4Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics. 2002, CA CancerJ Clin, 2005, 55.. 74-108.
  • 5Schifman M, Solomon D. Screening and prevention methods for cervical cancer. JAMA, 2009, 302.. 1809- 1810.
  • 6Wilkins MR, Sanchez JC, Cooley AA, et al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotech & Genetic EngineeringRev, 1995, 13: 19-50.
  • 7Simpson RJ, Bernhard OK, Greening DW, et al. Proteomics- driven cancer biomarker discovery., looking to the future. Curr Opin Chem Biol, 2008, 12:72 - 77.
  • 8Petricoin EF, Liotta LA. SELDI- TOF- based serum proteomics pattern diagnostics for early detection of cancer. Curr OpinBiotechnol, 2004, 15: 24-30.
  • 9Bae SM, Lee CH, Cho YL, et al. Two - dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol Oncol, 2005, 99.. 26- 35.
  • 10Arnouk H, Merkley MA, Podolsky RH, et al. Characterization of Molecular Markers Indicative of Cervical Cancer Progression. Proteomics Clin Appl, 2009, 3.. 516-527.

共引文献25

同被引文献28

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部